Collagen Peptides: Skin and Joint Evidence, Honestly Graded
What hydrolyzed collagen has shown for skin elasticity and joint comfort, why industry funding clouds the field, studied doses and who can skip it.
Read MoreWhat hydrolyzed collagen has shown for skin elasticity and joint comfort, why industry funding clouds the field, studied doses and who can skip it.
Read MoreWhy boswellia has some of the joint category's better trial results, the standardized extracts and doses studies used, and how it compares to expectations.
Read MoreWhy berberine has the glucose category's most interesting trial record, the doses studies used, its GI trade-offs, and the drug interactions that matter.
Read MoreWhat ashwagandha has actually shown in trials for stress and sleep, typical studied extracts and doses, liver-safety signals and who should avoid it.
Read MoreRCTs versus rat studies, surrogate outcomes, industry funding — a working primer for judging the studies supplement ads quote.
Read MoreThe handful of interaction classes behind most real supplement harm, absorption timing rules, and the pre-surgery stop list.
Read More60 versus 180 days, 'empty bottle' promises, deducted shipping fees — what refund terms really mean and the paper trail that wins disputes.
Read MoreHow a legal labeling format lets formulas hide their doses — and the ingredient-order math that partially exposes them.
Read More